Orange, a major French telecoms company, has held talks about investing in Vivendi’s pay-TV unit Canal Plus, according to people familiar with the matter.
No structure for the deal has been decided and the companies might instead agree to a partnership, the sources said. If there is an agreement, there is also no guarantee antitrust regulators would approve it.
On Thursday, Orange CEO Stéphane Richard said he was open to buying Canal Plus.
“If Canal Plus were up for sale tomorrow, Orange would definitely look into it. Obviously,” Mr. Richard told reporters on the fringes of a news conference in Morocco on Thursday. “There are many reasons that suggest forging closer ties.”
Paris-based Orange, France’s largest telecoms group, has seen margins squeezed at home by years of tough competition and is particularly interested in Canal Plus’ businesses in Poland and Africa where both companies have been expanding.
Vivendi, meanwhile, has been looking to foster relationships with large telecoms companies to better distribute its content.
Full Content: Market Watch
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas